Navigation Links
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Date:6/9/2008

out the 24-hour study period, as compared to placebo.

About Symphony Allegro

In December 2006, Alexza entered into a collaboration with Symphony Capital LLC, a biotech-focused private equity firm. Under the terms of the agreement, Alexza and Symphony Capital established Symphony Allegro, Inc., which is providing funding to Alexza to accelerate clinical and other related development activities of Staccato loxapine (AZ-004 and AZ-104) and Staccato alprazolam (AZ-002). Alexza has granted a license to certain intellectual property rights for the selected product candidates. Through a purchase option, Alexza retains the exclusive right, but not the obligation, to acquire 100% of the equity of Symphony Allegro at specified prices during the term of the agreement. If Alexza chooses not to exercise the purchase option, Symphony Allegro retains the rights to the product candidates. The purchase option expires December 31, 2010.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza has six product candidates in clinical development. Alexza's lead program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Ga., Dec. 16 Greenway Medical Technologies, ... electronic health record (EHR), practice management and interoperability ... in KLAS" awards in the annual 2009 ... & Professional Services report. ,, For practices ... Chart was named Best in KLAS in ...
(Date:12/16/2009)... -- Sanofi Pasteur, the vaccines division ... it has entered into an exclusive, world-wide ... commercialize its prophylactic vaccine against Staphylococcus, ... or MRSA. MRSA are responsible for several ... as multidrug-resistant Staphylococcus aureus because ...
(Date:12/16/2009)... 16 BioSpecifics Technologies Corp. (Nasdaq: ... class collagenase-based products, today announced top-line efficacy and ... of XIAFLEX(TM) for the treatment of Peyronie,s disease. ... inelastic collagen on the shaft of the penis, ... intercourse difficult or impossible in advanced cases. The ...
Breaking Medicine Technology:Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4Statewide program to improve emergency care for children 54567 1Statewide program to improve emergency care for children 54567 2Rodan + Fields Dermatologists Launch National Hispanic Outreach Campaign 54565 1Rodan + Fields Dermatologists Launch National Hispanic Outreach Campaign 54565 2Rodan + Fields Dermatologists Launch National Hispanic Outreach Campaign 54565 3USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer 9582 1
... practical grounds, direct programming is superior,to cloning as ... WASHINGTON, Nov. 20 Two major scientific,papers published ... proven way to,generate patient-matched human pluripotent stem cells ... embryos or human or animal eggs.,Research groups in ...
... and Consumer Groups calls for Legislative Action to ... Ensure Access to ,Off-Label, Drug Treatments, WASHINGTON, Nov. ... calling upon,Congress to pass legislation to require Medicare prescription drug ... drugs they cover. Medicare regulations exclude Part D coverage ...
Other Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities 2
(Date:12/16/2009)... to Benefit of Children with Autism and Other Special ... and Zachary Levi Join Ben Stiller to Ring in ... At its 13th annual Teddy Bear Ball, ... President & CEO Brian Goldner received ... his far-reaching philanthropic leadership and commitment to children,s causes; ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... --The most widely used human embryonic stem cell lines ... questions that must be addressed to ensure that all ... to a University of Michigan research team. ,, In ... team analyzed 47 embryonic stem cell lines, including most ... The scientists determined the genetic ancestry of each line ...
(Date:12/16/2009)... Scientists pinpoint seven that increase susceptibility to disease ... genes associated with increased susceptibility to leprosy have ... , The researchers, who analyzed more than 10,000 ... in China, said their discovery highlights the important ... the development of leprosy. , "Though leprosy is ...
(Date:12/16/2009)... University of Florida researchers at work on a malaria ... predict the spread of the disease using cell phone ... calls to determine how often residents of Zanzibar travel ... two islands off the coast of Tanzania in East ... Its government commissioned the study as part of deliberations ...
Breaking Medicine News(10 mins):Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3
... an ideal destination for medical tourism, the state's tourism department plans ... Sri Lanka and the Maldives. ,"A policy is ... have asked the CII (Confederation of Indian Industries) to give inputs ... shortly we would become the first state in the country to ...
... Legionnaires' outbreak in the Sydney CBD is linked to the ... authorities suspect//. However, they could not confirm the link. ... a bacteria belonging to the Legionella family, Legionella pneumophilia, have ... were in the Circular Quay area on New Year's Eve. ...
... at Rice University and pediatric specialists at Baylor College of ... buckyball nanoparticles as passkeys that allows drugs to enter cancer ... 21 issue of the journal Organic and Biomolecular Chemistry. ... outside world. Cell walls, or membranes, form a protective cocoon ...
... that a drug commonly used to lower blood pressure ... syndrome and also prevents muscle degeneration in mice with ... online this week at Nature Medicine. ,In ... discovered that treating Marfan mice with losartan (Cozaar) dramatically ...
... cancer surgeon were more likely to be treated by more ... an accredited cancer program, compared to women who were referred ... study led by researchers at the University of Michigan Comprehensive ... recently diagnosed with breast cancer in the Detroit and Los ...
... beneficial effect on the health of men. Some of the foods ... ,Vegetables like tomatoes, carrot, garlic and whole green are said ... and deep sea fish has the similar effect on men. ... also help in secretion of gastric acid. The vitamin C present ...
Other Medicine News:Health News:Buckyballs Used as 'Passkey' into Cancer Cells 2Health News:Common BP Drug Treats Muscular Dystrophy 2Health News:Common BP Drug Treats Muscular Dystrophy 3Health News:Are Women Seeing the Most Experienced Breast Cancer Surgeons? 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: